Dermatology5 articles

Impact 3

Sustained on/off-treatment disease control with abrocitinib for moderate-to-severe atopic dermatitis.

Published: 2026-12-01

The Journal of dermatological treatment

MediLens Indexed: 2026-05-23

This study evaluated the off-treatment disease control in patients with moderate-to-severe atopic dermatitis (AD) following 12 weeks of abrocitinib 200 mg. In the phase 3 JADE REGIMEN study, patients who achieved significant improvement were randomized to receive either placebo or continued treat...

Read on PubMed

Impact 2

Efficacy and safety of recombinant human epidermal growth factor combined with fractional carbon dioxide laser for facial atrophic acne scars: a systematic review and meta-analysis of randomized trials.

Published: 2026-05-22

Lasers in medical science

MediLens Indexed: 2026-05-23

This systematic review assessed the efficacy and safety of recombinant human epidermal growth factor (rhEGF) combined with fractional CO₂ laser therapy for atrophic acne scars. Twelve randomized controlled trials involving 1,044 patients were analyzed, showing significant reductions in ECCA and V...

Read on PubMed

Impact 2

Research on multi-stage deep learning based intelligent diagnosis of skin diseases and skin medicine diagnosis community construction concept.

Published: 2026-05-22

Scientific reports

MediLens Indexed: 2026-05-23

This study introduces a multi-stage intelligent diagnosis framework utilizing deep learning to enhance dermatological decision-making. The framework employs a LeNet-5 convolutional neural network for initial classification of skin diseases and further assesses disease severity and progression. By...

Read on PubMed

Impact 1

Pregnancy and risk of melanoma: a matched retrospective cohort study.

Published: 2026-05-22

Melanoma research

MediLens Indexed: 2026-05-23

This study investigates the relationship between pregnancy and melanoma risk using a large retrospective cohort. It found no significant increase in the risk of invasive melanoma or melanoma in situ during pregnancy compared to nonpregnant women of reproductive age. The findings suggest that preg...

Read on PubMed

Impact 3

Catestatin peptide impedes melanoma progression and drug resistance by reprogramming oncogenic signaling pathways.

Published: 2026-05-21

Oncogenesis

MediLens Indexed: 2026-05-23

This study investigates catestatin (CST), a peptide derived from Chromogranin A, as a potential therapeutic agent for melanoma. It demonstrates that CST expression decreases with disease progression, suggesting a tumor-suppressive role. Restoration of CST in melanoma cells led to apoptosis and re...

Read on PubMed

Medical Research Trends

Dermatology5 articles

Sustained on/off-treatment disease control with abrocitinib for moderate-to-severe atopic dermatitis.

Efficacy and safety of recombinant human epidermal growth factor combined with fractional carbon dioxide laser for facial atrophic acne scars: a systematic review and meta-analysis of randomized trials.

Research on multi-stage deep learning based intelligent diagnosis of skin diseases and skin medicine diagnosis community construction concept.

Pregnancy and risk of melanoma: a matched retrospective cohort study.

Catestatin peptide impedes melanoma progression and drug resistance by reprogramming oncogenic signaling pathways.

Get Personalized Daily Summaries